136 related articles for article (PubMed ID: 27652266)
41. Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma.
Leibovich BC; Sheinin Y; Lohse CM; Thompson RH; Cheville JC; Zavada J; Kwon ED
J Clin Oncol; 2007 Oct; 25(30):4757-64. PubMed ID: 17947723
[TBL] [Abstract][Full Text] [Related]
42. CAIX-targeting radiotracers for hypoxia imaging in head and neck cancer models.
Huizing FJ; Garousi J; Lok J; Franssen G; Hoeben BAW; Frejd FY; Boerman OC; Bussink J; Tolmachev V; Heskamp S
Sci Rep; 2019 Dec; 9(1):18898. PubMed ID: 31827111
[TBL] [Abstract][Full Text] [Related]
43. In vivo detection of head and neck cancer orthotopic xenografts by immunofluorescence.
Rosenthal EL; Kulbersh BD; Duncan RD; Zhang W; Magnuson JS; Carroll WR; Zinn K
Laryngoscope; 2006 Sep; 116(9):1636-41. PubMed ID: 16954995
[TBL] [Abstract][Full Text] [Related]
44. In vivo imaging of tumour xenografts with an antibody targeting the potassium channel K
Napp J; Pardo LA; Hartung F; Tietze LF; Stühmer W; Alves F
Eur Biophys J; 2016 Oct; 45(7):721-733. PubMed ID: 27444284
[TBL] [Abstract][Full Text] [Related]
45. Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts.
Ke S; Wen X; Gurfinkel M; Charnsangavej C; Wallace S; Sevick-Muraca EM; Li C
Cancer Res; 2003 Nov; 63(22):7870-5. PubMed ID: 14633715
[TBL] [Abstract][Full Text] [Related]
46. Synthesis and evaluation of near-infrared fluorescent sulfonamide derivatives for imaging of hypoxia-induced carbonic anhydrase IX expression in tumors.
Groves K; Bao B; Zhang J; Handy E; Kennedy P; Cuneo G; Supuran CT; Yared W; Peterson JD; Rajopadhye M
Bioorg Med Chem Lett; 2012 Jan; 22(1):653-7. PubMed ID: 22079760
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors.
Qi S; Miao Z; Liu H; Xu Y; Feng Y; Cheng Z
Bioconjug Chem; 2012 Jun; 23(6):1149-56. PubMed ID: 22621238
[TBL] [Abstract][Full Text] [Related]
48. Synthesis and evaluation of (18)F-labeled tertiary benzenesulfonamides for imaging carbonic anhydrase IX expression in tumours with positron emission tomography.
Lau J; Pan J; Zhang Z; Hundal-Jabal N; Liu Z; Bénard F; Lin KS
Bioorg Med Chem Lett; 2014 Jul; 24(14):3064-8. PubMed ID: 24878197
[TBL] [Abstract][Full Text] [Related]
49. Carbonic anhydrase IX promotes myeloid-derived suppressor cell mobilization and establishment of a metastatic niche by stimulating G-CSF production.
Chafe SC; Lou Y; Sceneay J; Vallejo M; Hamilton MJ; McDonald PC; Bennewith KL; Möller A; Dedhar S
Cancer Res; 2015 Mar; 75(6):996-1008. PubMed ID: 25623234
[TBL] [Abstract][Full Text] [Related]
50. Near-infrared fluorescent deoxyglucose analogue for tumor optical imaging in cell culture and living mice.
Cheng Z; Levi J; Xiong Z; Gheysens O; Keren S; Chen X; Gambhir SS
Bioconjug Chem; 2006; 17(3):662-9. PubMed ID: 16704203
[TBL] [Abstract][Full Text] [Related]
51. Carbonic anhydrase IX as a diagnostic urinary marker for urothelial bladder cancer.
de Martino M; Lucca I; Mbeutcha A; Wiener HG; Haitel A; Susani M; Shariat SF; Klatte T
Eur Urol; 2015 Oct; 68(4):552-4. PubMed ID: 26138037
[TBL] [Abstract][Full Text] [Related]
52. Intraoperative near-infrared fluorescence tumor imaging with vascular endothelial growth factor and human epidermal growth factor receptor 2 targeting antibodies.
Terwisscha van Scheltinga AG; van Dam GM; Nagengast WB; Ntziachristos V; Hollema H; Herek JL; Schröder CP; Kosterink JG; Lub-de Hoog MN; de Vries EG
J Nucl Med; 2011 Nov; 52(11):1778-85. PubMed ID: 21990576
[TBL] [Abstract][Full Text] [Related]
53. Molecular imaging of tumors with nanobodies and antibodies: Timing and dosage are crucial factors for improved in vivo detection.
Bannas P; Lenz A; Kunick V; Well L; Fumey W; Rissiek B; Haag F; Schmid J; Schütze K; Eichhoff A; Trepel M; Adam G; Ittrich H; Koch-Nolte F
Contrast Media Mol Imaging; 2015; 10(5):367-78. PubMed ID: 25925493
[TBL] [Abstract][Full Text] [Related]
54. Axl-targeted cancer imaging with humanized antibody h173.
Li D; Liu S; Liu R; Park R; Yu H; Krasnoperov V; Gill PS; Li Z; Shan H; Conti PS
Mol Imaging Biol; 2014 Aug; 16(4):511-8. PubMed ID: 24424460
[TBL] [Abstract][Full Text] [Related]
55. Carbonic anhydrase IX in bladder cancer: a diagnostic, prognostic, and therapeutic molecular marker.
Klatte T; Seligson DB; Rao JY; Yu H; de Martino M; Kawaoka K; Wong SG; Belldegrun AS; Pantuck AJ
Cancer; 2009 Apr; 115(7):1448-58. PubMed ID: 19195047
[TBL] [Abstract][Full Text] [Related]
56. Carbonic anhydrase IX is a marker of hypoxia and correlates with higher Gleason scores and ISUP grading in prostate cancer.
Ambrosio MR; Di Serio C; Danza G; Rocca BJ; Ginori A; Prudovsky I; Marchionni N; Del Vecchio MT; Tarantini F
Diagn Pathol; 2016 May; 11(1):45. PubMed ID: 27225200
[TBL] [Abstract][Full Text] [Related]
57. Semiautomatic landmark-based two-dimensional-three-dimensional image fusion in living mice: correlation of near-infrared fluorescence imaging of Cy5.5-labeled antibodies with flat-panel volume computed tomography.
Dullin C; Zientkowska M; Napp J; Missbach-Guentner J; Krell HW; Müller F; Grabbe E; Tietze LF; Alves F
Mol Imaging; 2009; 8(1):2-14. PubMed ID: 19344571
[TBL] [Abstract][Full Text] [Related]
58. Time-domain in vivo near infrared fluorescence imaging for evaluation of matriptase as a potential target for the development of novel, inhibitor-based tumor therapies.
Napp J; Dullin C; Müller F; Uhland K; Petri JB; van de Locht A; Steinmetzer T; Alves F
Int J Cancer; 2010 Oct; 127(8):1958-74. PubMed ID: 20473895
[TBL] [Abstract][Full Text] [Related]
59. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche.
Lock FE; McDonald PC; Lou Y; Serrano I; Chafe SC; Ostlund C; Aparicio S; Winum JY; Supuran CT; Dedhar S
Oncogene; 2013 Oct; 32(44):5210-9. PubMed ID: 23208505
[TBL] [Abstract][Full Text] [Related]
60. In vivo tumor imaging in mice with near-infrared labeled endostatin.
Citrin D; Lee AK; Scott T; Sproull M; Ménard C; Tofilon PJ; Camphausen K
Mol Cancer Ther; 2004 Apr; 3(4):481-8. PubMed ID: 15078992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
